Robin is ranked as one of the few leading practitioners in Life Sciences Regulation by Chambers & Partners. He has particular experience of advising food and drugs businesses facing regulatory investigation or criminal proceedings.
His criminal practice includes both prosecuting and defending life sciences businesses in regulatory cases, as well as advising on novel products (e.g. novel foods, novel psychoactive substances, and borderline medicinal products). He has been involved in a number of recent cases involving the regulation of Cannabidiol (CBD) products.
Robin’s civil life sciences practice includes strategic and perimeter advice for businesses and regulators, as well as judicial review of decisions taken by regulators.